Khawandi, Jana
Rao, Vinamratha
Rayner, Daniel G.
Girimaji, Niveditha
Azzam, Muayad
Hamarsha, Qais
Kawtharany, Hassan
Choaib, Ali
Qadir, Mustafa
Khan, Alysha
Sharma, Madhulika
Tran, Pamela
Fedeles, Sorin
Ruyle, Wendy
Yu, Alan S. L.
Hallows, Kenneth R.
Perrone, Ronald D.
Foroutan, Farid
Mustafa, Reem A.
Funding for this research was provided by:
Critical Path Institute
Article History
Received: 16 January 2026
Accepted: 13 May 2026
First Online: 3 June 2026
Declarations
Ethics approval and consent for publication: Not applicable.
Competing interests: R.A.M.: Led this systematic review under a contractual agreement between the University of Kansas Medical Center and PKDOC and has received research grants and consulting fees for other organizations not related to this work.J.K.: Coordinated the systematic review team completed under a contractual agreement between the University of Kansas Medical Center and PKDOC.S.F.: Served on the Scientific Advisory Board of Renasant Bio and received consulting fees.M.A., Q.H., H.K, A.C.: Review team members of this work completed under a contractual agreement between the University of Kansas Medical Center and PKDOCK.H.: Received research funding and consulting fees for other PKD-related studies from pharmaceutical companies.A.S.L.Y.: Received research funding and consulting fees for other PKD-related work. Serves on the PKD Foundation Scientific Advisory Board and is a Deputy Editor of the Journal of the American Society of Nephrology.R.P.: Received research funding and consulting fees for other PKD-related studies. Serves on the American Society of Nephrology Board Review Course faculty is a co-director of the PKD Outcomes Consortium and is a member of the PKD Foundation Registry Advisory Board.P.T.: Received grant support from the PKD Foundation for PKD-related work not associated with this work.M.S: Received a grant for another ADPKD-related project.All other authors: None.